Lundbeck
Michelle Ll. Estonilo has been a Senior Biopharmaceutical Account Manager at Lundbeck since August 2015, specializing in the launch of innovative migraine treatments and managing key accounts in neurology. As the founder of the Women’s Employee Resource Group, Women In Lundbeck Lead (WILL), Michelle has driven diversity and inclusion initiatives within the organization, including serving as a liaison with the Healthcare Businesswomen's Association and leading the HBA Ambassador Program. Prior experience includes roles at Zogenix, Bausch Health Companies, and Pfizer, focusing on neuroscience sales and training. Michelle holds a Bachelor of Science degree in Real Estate and International Business from Penn State University, with additional studies in Singapore and Spain.
This person is not in any teams
This person is not in any offices
Lundbeck
42 followers
Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at disease areas such as depression, schizophrenia, Parkinson’s disease and Alzheimer’s disease.